Login
  • Therapeutic Area
    • Metabolic
  • Resources
  • Contact
Login

  • Add
  • CV DEATH HAS A NEW OPPONENT
    In patients with type 2 diabetes
    with high CV risk

    CV DEATH 
    HAS A 
    NEW OPPONENT

    Jardiance® (Empagliflozin) is the only type 2 diabetes pill proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease
     
    Close ×
    • Therapeutic Area
    • Metabolic
    • Resources
    • Videos
    • Clinical studies
    • Site map
    • Terms of use
    • Privacy
    • Contact
    • Change country

    © 2010-2026
    Boehringer Ingelheim International GmbH.
    All rights reserved.